- Home
- ANVS vs QXL Comparison
ANVS vs QXL Comparison
Compare ANVS & QXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | QXL |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.6M | 75.6M |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ANVS | QXL |
|---|---|---|
| Price | $1.13 | $4.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 997.8K | 30.9K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.39 | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $26,941,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $45.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.22 | $4.05 |
| 52 Week High | $5.50 | $7.70 |
Technical Indicators
Market Signals| Indicator | ANVS | QXL |
|---|---|---|
| Relative Strength Index (RSI) | 22.48 | 45.93 |
| Support Level | N/A | $4.19 |
| Resistance Level | $2.02 | $5.04 |
| Average True Range (ATR) | 0.10 | 0.28 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 3.65 | 39.24 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
About QXL Quantum X Labs Inc. Common Stock
Quantum X Labs Inc is an Israel-based multi-disciplinary quantum technology company focused on the research, development, and commercialization of quantum technologies and intellectual property. The company operates across a broad range of domains, including quantum computing, quantum sensing, navigation systems, atomic clocks, and quantum algorithms, with applications spanning defense, aerospace, transportation, cybersecurity, and life sciences.